Amgen Adopts PhRMA's Guiding Principles for Direct-to-Consumer Advertising

Strategic Insights -

As a pioneer in direct-to-consumer (DTC) advertising, Amgen has announced its commitment to upholding the Pharmaceutical Research and Manufacturers of America's (PhRMA) Guiding Principles on DTC advertising. By signing onto these voluntary principles, Amgen recognizes the potential of DTC advertising to increase awareness about diseases, educate patients about treatment options, and encourage dialogue between patients and physicians. Amgen's executive vice president, George Morrow, emphasized that the intent of DTC advertising is to facilitate appropriate care for under-diagnosed and under-treated conditions. Amgen's guidelines go beyond FDA regulations, mandating pre-clearance through the FDA for all initial drug product DTC television and print advertisements. By adhering to these principles, Amgen aims to maximize the effectiveness of DTC advertising and prioritize patient education.

Key Takeaways:

  • Amgen has become a signatory to PhRMA's Guiding Principles on DTC advertising, ensuring responsible and informative DTC practices.
  • The guidelines encourage DTC advertising to educate patients about medicine and, when necessary, the condition being treated.
  • Companies should educate healthcare professionals before initiating a new DTC campaign to facilitate meaningful dialogue.
  • PhRMA's guidelines require DTC television ads to be submitted to the FDA for review before airing.
  • DTC advertising should present risks and safety information in clear language, without distraction from the content.

Statistics:

  • 1 January 2006: Amgen's guidelines will go into effect, aligning with PhRMA's guidelines.
  • 29 July 2005: PhRMA approved the Guiding Principles on DTC advertising.
  • 5: The number of principles outlined by PhRMA, exceeding FDA regulations.
  • 2006: The year Amgen's guidelines will become effective.

Sources:

  • Proposition 205 (approved July 29, 2005)

(Proposition 205 is likely a typo, and it should be "approved July 29, 2005" without the Proposition 205)